Key Takeaways
- Strong quarter, India-led: Revenue grew 14% QoQ and 12% YoY, with EBITDA up 20% QoQ, driven by a broad-based India performance and the first-time consolidation of SEMCO.
- Agrochemicals are back: After an 18-24 month pause, two large agrochemical clients have resumed investing, a material tailwind for the core glass-lined business.
- Diversification is now visible in the numbers: The strategy to move beyond glass-lined into systems, heavy engineering, and new geographies is offsetting continued softness in European chemical and pharma.
- The order book target is already met: Internal order booking targets for FY26 have been hit, and management hopes to exit the year with a 15-20% stronger backlog than prior years.
- What to watch next quarter: Whether the "green shoots" in international service activity convert into actual order decisions, and the pace of heavy engineering order intake from nuclear and green hydrogen.
India Business: The Growth Engine
- Broad-based strength: Revenue and order intake performed well across all three lines: glass-lined, non-glass-lined, and heavy engineering. The order backlog is well diversified.
- Agrochemical revival: Two large clients restarted investment after an 18-24 month hiatus. The spend is not back to peak levels, but it is a meaningful positive shift for glass-lined demand.
- Systems share rising: A new test center near the Gujarat facility and new product development are enabling GMM to replace products previously sourced from Europe. Customers increasingly want complete systems with instrumentation, automation, and glove boxes.
- Pharma/peptide traction: Semaglutide/GLP-1 demand is picking up in India, with a large contract being executed for a peptide manufacturer in south India. Technology from the Mavag subsidiary provides competitive differentiation.
- Heavy engineering building: Large orders have been received and the backlog is growing. Approvals from the HDO acquisition are being passed on to GMM, and the company is well-positioned for nuclear industry opportunities in India.
Tarak Patel: "two of our big agrochemical clients after really an 18-month, 24-month sabbatical have now started investing again. So, it is not back to the original Heydays when they were adding plants every six months. But there is definitely some amount of investment that is coming back."
International: Soft Core, Diversified Growth
- Europe still slow: Traditional chemical and pharma industries remain weak, with Germany particularly uncertain. However, newer segments like acid recovery systems for nitric acid production are seeing an uptick, including a large order last quarter.
- US showing slight improvement: The Make in US initiative and signed contracts could help if chemical and pharma investments materialize. The Edlon subsidiary, driven by semiconductors, is growing.
- South America opens up: The SEMCO acquisition provides a strong brand and order book in metals, minerals, mining, and water treatment. SEMCO has a year's worth of backlog and is negotiating large opportunities.
- International services flattish: Revenue growth is roughly 1% YoY as lower equipment utilization at customer sites reduces service demand. Europe is weak and there may have been slight market share loss, which management is addressing. The US market is strong as GMM is the only local manufacturer.
- China recovery expected next year: Build-over capacities are currently being used up, keeping the market slow. Management expects a return by next year.
Thomas Kehl: "we are seeing a little bit of uptake in service activities as well as in America as Europe. This is surely a sign that our customers are getting more busy than they have been the last quarter. And that takes us to believe that the increase in order of decisions will come."
M&A Integration & Platform Strategy
- SEMCO consolidated: The acquisition closed and was consolidated for Q2 FY26, contributing to the 14% QoQ revenue growth. Purchase price was USD 1.85 crore (INR 162 crores), funded by a 10 million euro acquisition facility and internal cash.
- Poland JV operational: First-time consolidation this quarter. The workshop executes orders for Mavag (Switzerland) and Mixel (France), with initial orders delivered at very high quality. More fabrication work is expected to migrate to this lower-cost geography over time.[11-12]
- Mixing platform strategy: Management is building a global mixing business around four platforms, each with a segment focus: SEMCO for metals/minerals/mining, MixPro for chemicals, India for pharma, and Mixel for biotech. A rebranding strategy to unite them under one umbrella is underway.
- PPA pending: Both acquisitions are currently accounted for as goodwill only. Purchase price allocation will be conducted over the next 12 months, and goodwill will be adjusted accordingly.
Heavy Engineering & New Verticals
- Nuclear opportunity materializing: GMM received a split order from NPCIL to supply heat exchangers for primary and secondary circuits in nuclear power plants. This is expected to be a continuous opportunity over the next five years.
- Green hydrogen entry: One order has already been executed for a German EPC serving an Indian end customer, supplying heat exchangers for hydrogen plants.
- Export ambitions: Heavy engineering is currently focused on the domestic market, but management is looking to expand exports to the Middle East, US, and Europe. Approvals from EPC companies in the US and Europe are being obtained.
- Flow chemistry still nascent: GMM has built a flow chemistry set-up at its Karamsad facility for customer trials and is working with NCL and a UK firm on new technologies. Adoption has not yet taken off in a big way; only specific chemical reactions are suited to flow, and batch processing will continue.
Glass-Lined Core: Discipline Over Volume
- Capacity consolidated and full: The Hyderabad facility has been closed, and all production now flows through Karamsad, which is running three shifts with furnaces at capacity. Previously, the two factories operated at 50-70% utilization.
- Pricing stabilized: Rationalization has been achieved and stability has returned. As the market improves and inquiries increase, there may be further opportunity to raise prices. Steel and gas cost increases are passed on over time.
- No capacity-led price war: Management can quickly add a furnace if needed but is explicit that it will not do so if it means starting a price war to fill it. The core chemical and pharma market remains important, but it will not drive significant growth given GMM's 40-50% market share.
Tarak Patel: "I do not want to be in a situation where to fill capacity we have to start again kind of going into a price war."
Financial Health & Working Capital
- Working capital elevated, H2 improvement expected: The increase in H1 was driven by higher inventory in India, built as a basis for expected growth. Receivables also increased. Management expects improvement in the remainder of FY26.
- FX impact normalized: The previous quarter had a significant USD/EUR depreciation causing a financial loss and higher tax rate. This quarter, the euro-USD rate did not change significantly, positively impacting results and the tax rate on international business.
- Employee cost increase explained: The rise was not due to new hiring but part of a tax optimization strategy involving internal recharges. Integration costs are now visible in the India entity.
- Leverage target: Management's long-term guidance is to keep leverage below one.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Order backlog exit rate | Hope for at least 15-20% improvement over previous years | FY26 year-end (March 2026) |
| Working capital | Expect improvement in H2 | Remainder of FY26 |
| Nuclear order intake | Expect order intake; management is bullish | At least this quarter |
| China recovery | Expect the Chinese market to come back | By next year |
| Leverage | Keep below one | Long-term guidance |
| Glass-lined pricing | Steel and gas price increases get passed on; further opportunity to increase prices as market improves | Over time |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Revenue | ₹902 cr, +14% QoQ and +12% YoY |
| EBITDA | ₹122 cr, +20% QoQ and +27% YoY |
| EBITDA margin | 13.5% |
| H1 FY26 revenue growth | +7% YoY |
| H1 FY26 EBITDA growth | +21% YoY |
| Order intake | ₹878 cr |
| Order backlog | ₹2,146 cr, includes SEMCO backlog of $20 mn |
| International technologies revenue growth | +9.2% YoY; ex-SEMCO, growth would be "pretty flat" |
| Heavy engineering revenue (FY25) | ₹260 cr; H1 FY26 growth of ~15% |
| India order book | ₹90–100 cr higher QoQ |
| Glass-lined market share | 40–50% |
| Glass-lined Karamsad backlog | 5–6 months |
| Services share of order backlog | ~10% |
| Unfunded pension liabilities | ₹312 cr, increased ~₹30 cr over FY25 |
| Unrealized forex loss (H1) | ₹56 cr, primarily from Q1 euro-USD movement |
| SEMCO acquisition price | $1.85 cr (₹162 cr); funded partly by €10 mn acquisition facility |
| Poland JV investment | 1.1 cr Polish zloty (~₹25 cr) |
| Goodwill increase | ~₹200 cr, mainly from SEMCO acquisition |